Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review

Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems of therapeutic compounds. The company harnesses its proprietary sublingual spray technology to develop pharmaceutical cannabinoids. Its marketed products inlcude Subsys, a sublingual fentanyl spray for breakthrough cancer pain (BTCP) and Syndros (dronabinol oral solution), an orally administered liquid formulation of dronabinol for the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in AIDS patients. The company offers its products to oncologists, pain specialists and supportive care centers for the potential treatment of addiction to opioids, opioid overdose and epilepsy. It has operations in the US and offers its products in international markets. Insys is headquartered in Chandler, Arizona, the US.

Insys Therapeutics Inc Key Recent Developments

Mar 25,2019 INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Drug Dependence Annual Scientific Meeting
Mar 07,2019 INSYS Therapeutics reports fourth quarter and full year 2018 results
Jan 09,2019 INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatment of Anaphylaxis

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

LIST OF TABLES

Insys Therapeutics Inc, Key Facts
Insys Therapeutics Inc, Key Employees
Insys Therapeutics Inc, Key Employee Biographies
Insys Therapeutics Inc, Major Products and Services
Insys Therapeutics Inc, History
Insys Therapeutics Inc, Other Locations
Insys Therapeutics Inc, Subsidiaries
Insys Therapeutics Inc, Key Competitors
Insys Therapeutics Inc, Ratios based on current share price
Insys Therapeutics Inc, Annual Ratios
Insys Therapeutics Inc, Annual Ratios (Cont...1)
Insys Therapeutics Inc, Interim Ratios
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Insys Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Insys Therapeutics Inc, Performance Chart (2014 - 2018)
Insys Therapeutics Inc, Ratio Charts
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

West Therapeutic Development LLC
Teva Pharmaceutical Industries Ltd
Sentynl Therapeutics Inc
SELLAS Life Sciences Group Inc
Sanofi
Roche Holdings Inc
Par Pharmaceutical Holdings Inc
Par Pharmaceutical Companies, Inc.
Merck & Co Inc
Mallinckrodt LLC
Kyowa Hakko Kirin Co Ltd
GW Pharmaceuticals Plc
GlaxoSmithKline Plc
BioDelivery Sciences International Inc
Assertio Therapeutics Inc
AbbVie Inc